understanding of processes within the ocean that 
may affect human health and to explore the poten-
tial contribution of marine organisms to medicine 
and research, including— 
‘‘(A) vector-, water-, and food-borne dis-
eases of humans and marine organisms, includ-
ing marine mammals, corals, fish, and shellfish; 
‘‘(B) human health effects associated with 
harmful algal blooms and hypoxia (in collabora-
tion with the Inter-Agency Task Force on 
Harmful Algal Blooms and Hypoxia); 
‘‘(C) marine-derived pharmaceuticals and 
other natural products; 
‘‘(D) marine organisms and habitats as 
models for biomedical research and as indica-
tors of human health and well being and marine 
environmental health; 
‘‘(E) marine environmental microbiology 
linked to human health; 
‘‘(F) human health effects associated with 
legacy and emerging chemicals of concern, in-
cluding 
bioaccumulative 
and 
endocrine-dis-
rupting chemical contaminants; 
‘‘(G) predictive models of public health 
risks based on indicators and assessments of 
VerDate Mar 15 2010 
20:33 Dec 07, 2011
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H3570.IH
H3570
jlentini on DSK4TPTVN1PROD with BILLS
marine ecosystem health and marine animal 
health; and 
‘‘(H) social, economic, and behavioral stud-
ies of relationships between the condition of 
oceans, coasts, and the Great Lakes and human 
health and well-being, risk communication, and 
decision-making processes. 
‘‘(2) Coordination with appropriate interagency 
working groups of the Subcommittee on Ocean 
Science and Technology, or its successor body, 
through the National Science and Technology Coun-
cil, to ensure that any integrated ocean and coastal 
observing system provides information necessary to 
monitor and reduce marine public health problems, 
including climate change information, health-related 
data on biological populations, and detection of tox-
ins and contaminants in marine waters and sea-
food.’’; and 
(2) in paragraph (3)— 
(A) in subparagraph (A), by striking 
‘‘genomics and proteomics’’ and inserting 
‘‘genomics, proteomics, metabolomics, and other 
related sciences’’; 
(B) by striking subparagraph (C) and in-
serting the following: 
VerDate Mar 15 2010 
20:33 Dec 07, 2011
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H3570.IH
H3570
jlentini on DSK4TPTVN1PROD with BILLS
‘‘(C) in situ, laboratory, and remote sen-
sors— 
‘‘(i) to detect, quantify, and predict 
the presence, distribution, concentration, 
toxicity, or virulence of infectious microbes, 
harmful algae, toxins, and chemical con-
taminants in ocean waters, sediments, or-
ganisms, and seafood; and 
‘‘(ii) to identify new genetic resources 
for biomedical purposes;’’; and 
(C) in subparagraph (E), by striking 
‘‘equipment and technologies’’ and inserting 
‘‘equipment, technologies, and methodologies 
used in human health, and other fields, for ap-
plication to oceans and human health objec-
tives’’. 
(d) BIENNIAL REPORT.—Section 902(d) (33 U.S.C. 
3101(d)) is amended— 
(1) by striking ‘‘Annual’’ in the heading and in-
serting ‘‘Biennial’’; 
(2) in the matter preceding paragraph (1)— 
(A) by striking ‘‘Beginning with the first 
year occurring more than 24 months after the 
date of enactment of the Act, the’’ and insert-
ing ‘‘The’’; 
VerDate Mar 15 2010 
20:33 Dec 07, 2011
Jkt 019200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H3570.IH
H3570
jlentini on DSK4TPTVN1PROD with BILLS